Xu Jiandong
SEC CIK 1920399 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ESLA | Estrella Immunopharma, Inc. | CFO | 365.5K | $2,594 | — | 3 | 2025-09-11 | 2026-08-18 |
Most active insiders at ESLA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Liu Cheng | CEO, Dir | — | — |
| 2 | Xu Jiandong | CFO | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-25 21:55 | 2026-08-18 | ESLA | Estrella Immunopharma, Inc. | Xu Jiandong | CFO | M - OptEx | $0.815 | +100.0K | 365.5K | +38% | +$81.5K |
| M | 2026-04-29 21:36 | 2025-09-11+ | ESLA | Estrella Immunopharma, Inc. | Xu Jiandong | CFO | P - Purchase | $1.30 | +1,100 | 265.5K | +0.4% | +$1,434 |
| I | 2026-04-29 21:36 | 2025-09-22 | ESLA | Estrella Immunopharma, Inc. | Xu Jiandong | CFO | P - Purchase | $1.16 | +1,000 | 16.7K | +6% | +$1,160 |
Purchase Sale Sale after option exercise All abbreviations